
Nano4Imaging GmbH is a medical device company specializing in MRI-visible medical devices and implants for interventional procedures, particularly in cardiovascular treatments. Their key products include the EmeryGlide guidewire, MagnaFy MRI markers, and TRACKR AI software, which enhance MRI-guided interventions by improving device visibility and navigation. The company offers B2B and OEM services, with FDA 510-K clearance for the EmeryGlide guidewire. Their technology integrates deep learning for real-time device detection, supporting interventional MRI procedures. Nano4Imaging operates internationally with offices in Germany and the USA, targeting medical device manufacturers and healthcare providers in cardiovascular and radiotherapy fields.

Nano4Imaging GmbH is a medical device company specializing in MRI-visible medical devices and implants for interventional procedures, particularly in cardiovascular treatments. Their key products include the EmeryGlide guidewire, MagnaFy MRI markers, and TRACKR AI software, which enhance MRI-guided interventions by improving device visibility and navigation. The company offers B2B and OEM services, with FDA 510-K clearance for the EmeryGlide guidewire. Their technology integrates deep learning for real-time device detection, supporting interventional MRI procedures. Nano4Imaging operates internationally with offices in Germany and the USA, targeting medical device manufacturers and healthcare providers in cardiovascular and radiotherapy fields.
Headquarters: Düsseldorf, Germany
Core product areas: MRI-visible devices (EmeryGlide guidewire, MagnaFy markers) and trackr.ai navigation software
Regulatory milestone: FDA 510(k) clearance for EmeryGlide guidewire
Founding year: 2011
Reported employees: Approximately 15
Recent funding signal: Dec 19, 2022 grant led by the European Innovation Council
Interventional MRI device visibility and navigation for cardiovascular and radiotherapy procedures
2011
Medical devices / Medtech
Reported EIC Accelerator / grant awarded
Public profiles report earlier seed/venture rounds (multiple investors reported across rounds)
“Investors reported include European Innovation Council, BioScience Ventures Group, Limburg Ventures, and TechVision Fund”